This Article Full Text Full Text (PDF) All Versions of this Article: 54/2/210    most recent HYPERTENSIONAHA.109.129742v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Delou, J. M. A. Articles by Capella, M. A.M. PubMed PubMed Citation Articles by Delou, J. M. A. Articles by Capella, M. A.M. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Related Collections ACE/Angiotension receptors Animal models of human disease Hypertension - basic studies Ion channels/membrane transport Endothelium/vascular type/nitric oxide

(Hypertension. 2009;54:210.)
© 2009 American Heart Association, Inc.

Brief Reviews

Unveiling the Role of Multidrug Resistance Proteins in Hypertension

From the Instituto de Bioquímica Médica (J.M.A.D., M.A.M.C.) and Instituto de Biofísica Carlos Chagas Filho (A.G.L., M.A.M.C.), Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Correspondence to Márcia A.M. Capella, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, CCS-Bloco G, 21949-900 Rio de Janeiro, RJ, Brazil. E-mail mcapella@biof.ufrj.br

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Hypertension is a chronic condition associated with an increased risk of mortality and morbidity. It is estimated to cause 4.5% of current global disease burden, and its prevalence is similar in both developing and developed countries.¹ According to a recent review, 54% of stroke, 47% of ischemic heart disease, 75% of hypertensive disease, and 25% of other cardiovascular disease worldwide can be attributable to high blood pressure.²

Altered levels of angiotensin and aldosterone are common findings in hypertension. Aldosterone has been shown to play an important role in the pathophysiology of numerous cardiovascular disorders, including heart failure and hypertension,³ and the renin-angiotensin-aldosterone system is currently an important target for 5 antihypertensive drug classes: β-blockers, renin inhibitors, angiotensin-conversion enzyme inhibitors, angiotensin receptor blockers, and aldosterone antagonists.⁴

In the last few years, increasing evidence has pointed to an involvement of multidrug resistance (MDR)-related proteins with hypertension. Both ABCB1 (P-glycoprotein) and ABCC1 (MDR-associated protein 1), the 2 main proteins first described in multidrug-resistant tumors, are known to physiologically transport several endobiotics, including hormones.^5,6 Moreover, ABCB1 and ABCG2 (the third protein related to MDR), seem to also be related to the secretion of several drugs to urine, including some antihypertensives.^7,8 This review summarizes the recent findings regarding the relationship between MDR-related proteins and hypertension.

	ABC Superfamily and MDR in Cancer

 
MDR is still the main cause of failure in cancer chemotherapy. Although it is a multifactorial phenomenon, virtually all MDR cells present an ATP-dependent reduction in intracellular drug accumulation because of the overexpression of 1 of 3 proteins belonging to . . . [Full Text of this Article]